| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
2,442.35
|
|
Change (%)
|
98.95 (4.22%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
2,350.05
-
2,459.00
|
|
52-Week Range (RS)
|
1,838.65
-
2,459.00
|
|
Beta (1 Year)
|
0.49
|
|
|
|
|
|
| Index Details |
| BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Shariah 50 |
| News |
|
Corporate Details |
| Lupin wins USFDA approval for Glycerol Phenylbutyrate oral liquid |
| Lupin allots 36,752 equity shares under ESOP |
| Lupin to convene board meeting |
| Lupin launches diabetes drug in U.S. after FDA nod |
| Lupin's New Jersey-based facility gets Form-483 with three observations from US FDA |
| Lupin's US arm enters into USD 30 million settlement agreement with Humana |
| Lupin's US arm settles civil antitrust litigation with Humana for $30 million |
| Lupin incorporates WoS in Thailand |
| Lupin launches generic Dapagliflozin tablets in US after FDA nod |
| Lupin grants 6,495 stock options under ESOP |
|
|
|
| Incoporation Year : 1983 |
| Chairman : M D Gupta |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Lupin Ltd Kalpataru Inspire 3rd Floor, Off Western Exp HW Santacruz-E, Mumbai, Maharashtra-400055 |
Phone:91-22-6640 2323 Fax:91-22-6640 8131 |
| E-Mail : investorservices@lupinpharma.com |
URL : https://www.lupin.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
28-Apr-2026 |
2302.10 |
1.79 |
| 1Month |
06-Apr-2026 |
2277.90 |
2.88 |
| 3Month |
05-Feb-2026 |
2217.40 |
5.68 |
| 6Month |
06-Nov-2025 |
1956.05 |
19.80 |
| 1Year |
05-May-2025 |
2087.30 |
12.27 |
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| HDFC Balanced Advantage Fund |
1.34 |
1315.79 |
| HDFC Large Cap Fund |
3.01 |
1068.09 |
| HDFC Flexi Cap Fund |
1.06 |
971.84 |
| Mirae Asset Large & Midcap Fund |
2.41 |
919.69 |
| Nippon India Pharma Fund |
8.45 |
667.33 |
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Sun Pharmaceutical Industries Ltd |
1,850.40 |
1.63 |
1,857.95 |
1,547.25 |
443,972.94 |
| Cipla Ltd |
1,365.25 |
2.38 |
1,672.20 |
1,165.55 |
110,282.52 |
| Dr Reddys Laboratories Ltd |
1,310.50 |
3.11 |
1,377.95 |
1,121.20 |
109,381.80 |
| Mankind Pharma Ltd |
2,361.90 |
1.78 |
2,726.75 |
1,909.90 |
97,505.92 |
| Zydus Lifesciences Ltd |
939.10 |
2.99 |
1,059.00 |
835.85 |
94,495.43 |
|
|
|
|